BUMETANIDE AND HEARING LOSS: RESULTS OF A PHASE I/II DOSE FINDING AND FEASIBILITY TRIAL OF BUMETANIDE FOR SECOND LINE TREATMENT OF NEONATAL SEIZURES (NEMO)

Ronit Pressler,Geraldine B. Boylan,L.S. de Vries,Neil Marlow,Sampsa Vanhatalo,Jullien,Sarah Zohar,B. Mats,Boubou Hallberg,J.H. Cross,Catherine Chiron,M I Levene,Barry Mangum,Gérard Pons,Lena Hellström-Westas,Brendan P. Murphy,Deirdre Murray,Janet M. Rennie,R.M. Swarte,Mona C. Toet

BUMETANIDE AND HEARING LOSS: RESULTS OF A PHASE I/II DOSE FINDING AND FEASIBILITY TRIAL OF BUMETANIDE FOR SECOND LINE TREATMENT OF NEONATAL SEIZURES (NEMO)

2014

Bumetanide and Hearing Loss : Results of a Phase I/Ii Dose Finding and Feasibility Trial of Bumetanide for Second Line Treatment of Neonatal Seizures (Nemo)

Keywords:

Hearing loss
Anesthesia
Bumetanide
Medicine
phase i ii
dose finding
clinical neurology
second line treatment

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations